Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • FEI Celebrates Shipment of 1,000th Helios DualBeam System

    Aug 31, 2016, 18:43 PM by Michael Croft
    HILLSBORO, OR - Aug 31, 2016 - FEI (NASDAQ: FEIC) today announced a milestone of the 1,000th Helios™ DualBeam system shipped since the product family was introduced in 2006
    Full story
  • Biogen’s Plaque-Busting Alzheimer’s Drug Shows Promise

    Aug 31, 2016, 14:48 PM by Michael Croft
    MIT Technology Review | An antibody that clears up brain-destroying plaques may settle the cause of Alzheimer's once and for all.
    Full story
  • How DNA Could Store All the World’s Data

    Aug 31, 2016, 11:33 AM by Michael Croft
    Nature News & Comment | Modern archiving technology cannot keep up with the growing tsunami of bits. But nature may hold an answer to that problem already.
    Full story
  • Novartis Dissolves CAR-T Unit Cutting 120 Positions

    Aug 31, 2016, 11:32 AM by Michael Croft
    Forbes | Novartis is shutting down the business unit it created to develop white blood cells that can attack certain types of cancer, but continuing to develop such projects known as chimeric antigen receptor T-cells, or CAR-Ts.
    Full story
  • Recipharm establishes long term supply agreement with Tillotts Pharma AG

    Aug 31, 2016, 05:28 AM by Michael Croft
    STOCKHOLM, SWEDEN - Aug 31, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), announces that it has entered into a long term supply agreement with Tillotts Pharma AG
    Full story
  • Say hello to Dell Technologies on Sept. 7

    Aug 30, 2016, 16:46 PM by Michael Croft
    Computerworld | Dell will complete its acquisition of EMC on Sept. 7, ending nearly a year of approvals and decades of history for the two companies that will combine to become Dell Technologies.
    Full story
  • Excel Auto-Correct Creates Problems With Genomics Research

    Aug 30, 2016, 13:14 PM by Michael Croft
    PCMAG | An Excel auto-correct feature changes gene names to dates. An Australian group dug through 7,500 Excel files published in 18 journals. About 20% of the files had errors.
    Full story
  • tranSMART, IDBS, JAX and more: News from August 2016

    Aug 30, 2016, 10:45 AM by Michael Croft
    Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from tranSMART, JAX, Internet2, IDBS, Synthego, and more.
    Full story
  • The Genetics of Type 2 Diabetes Is a Mess

    Aug 29, 2016, 13:06 PM by Michael Croft
    Pacific Standard | A recent study shows why genetic advances in medicine are so challenging.
    Full story
  • Recipharm increases lyophilisation capacity in Italy

    Aug 26, 2016, 12:15 PM by Michael Croft
    MASATE, ITALY - Aug 26, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced a €3.7 million investment to expand its lyophilisation capacity in Masate, Italy, in response to growing customer demand
    Full story
  • Digitizing The Pharma Research Value Chain For Faster Drug Discovery Through Precompetitive Collaboration

    Aug 26, 2016, 09:45 AM by Michael Croft

    Bio-IT World Contributed Commentary | The global pharmaceutical industry is at a crossroads. It is, therefore, imperative for pharma organizations to reimagine their research value chain, in order to accelerate product innovation, and boost molecule pipelines during the discovery stage.

    Full story
  • Stealthy Biotech Revives Stalled Parkinsons Drug Reveals Plans In Alzheimers and ALS

    Aug 25, 2016, 17:19 PM by Michael Croft
    Forbes | Denali Therapeutics, the stealthy South San Francisco biotech startup that raised $217 million last year to fight Alzheimer's, Parkinson's and ALS, is finally lifting the curtain on its plans this morning.
    Full story
  • Bio-Rad Introduces an Assay Website That Allows Researchers to Identify or Design Their Own Droplet Digital™ PCR Assays

    Aug 24, 2016, 18:23 PM by Michael Croft
    HERCULES, CA, UNITED STATES - Aug 9, 2016 - Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of an assay website that allows droplet digital PCR (ddPCR™) users to locate existing assays or design new ones for mutation detection and copy number determination
    Full story
  • Bioclinica Enters Agreement to be Acquired by Cinven

    Aug 23, 2016, 11:41 AM by Michael Croft
    DOYLESTOWN, PA, US - Aug 23, 2016 - Bioclinica®, a provider of specialized technology-enabled services supporting clinical trials, today announced that it has entered a definitive agreement to be acquired by Cinven, a leading international private equity firm
    Full story
  • MDI Biological Laboratory Scientists Awarded Patent for Potential New Heart Disease Drug

    Aug 23, 2016, 11:34 AM by Michael Croft
    BAR HARBOR, ME - Aug 23, 2016 - The U.S. Patent and Trademark Office has announced that it will grant a patent to MDI Biological Laboratory scientists Voot P
    Full story
  • Is the virtual gene panel the way forward, asks Congenica at Dx Summit

    Aug 23, 2016, 07:54 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Aug 23, 2016 - Although the current practice of analysing defined gene panels for a specific disease has great utility, it is of limited benefit when a condition is not well defined
    Full story
  • Obama’s science legacy betting big on biomedical science

    Aug 22, 2016, 13:30 PM by Michael Croft
    Nature News & Comment | Ambitious bids to map the brain and cure cancer have not boosted overall research funding.
    Full story
  • With $14 Billion Purchase Pfizer Signals That Cancer Drug Prices Will Remain High

    Aug 22, 2016, 13:20 PM by Michael Croft
    Forbes | Pfizer says it will purchase biotechnology upstart Medivation for $14 billion in cash. The main prize in the deal: Medivation's prostate cancer drug, Xtandi, which costs $120,000 a year.
    Full story
  • PHARMA TECH FIRM EXPANDS US PRESENCE

    Aug 19, 2016, 08:09 AM by Michael Croft
    - Aug 19, 2016 - ZENITH Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services
    Full story
  • Mass Innovation Labs Host Space for Growing Biotech

    Aug 19, 2016, 05:05 AM by Michael Croft
    Bio-IT World “Something that the industry doesn’t really talk about is the cost of doing research,” says Amrit Chaudhuri, CEO of Mass Innovation Labs in Cambridge, Mass. Running a lab can cost hundreds of dollars per square foot, Chaudhuri says, but Mass Innovation Labs offers an alternative.
    Full story
  • «
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338 (current)
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy